New Market Study Published: EU Biosimilars Database

New Pharmaceuticals market report from Datamonitor: "EU Biosimilars Database"

by Bill Thompson

(WireNews+Co) - Boston, MA - 28 October 2012

Details of all marketed and pipeline biosimilars in the EU. View by product, selecting a molecule name; assess a biosimilar company's pipeline; or view the full pipeline and filter on all 11 labels.

Scope
- Pipeline: details of the full pipeline of products, select all or filter by country and sort by a variety of criteria
- Product: select an individual product and view details of all associated biosimilars in development in the EU
- Company: select either a biosimilar source company or a partner company to view details of all biosimilar products in its EU portfolio

View Full Report Details (http://www.fastmr.com/prod/464856_eu_biosimilars_database.aspx) (http://www.fastmr.com/prod/464856_eu_biosimilars_database.aspx)

Highlights

Database of marketed and pipeline biosimilars in the EU, based on company-reported information and a variety of other sources.

Reasons to Get this Report
- Identify which products are being targeted by biosimilars developers and which companies are active in the EU biosimilars market
- Analyze the pipeline of biosimilar products in development in the EU by therapy area, molecule type and company amongst other criteria

Report Table of Contents:

EU BIOSIMILARS DATABASE

- Access the database
- Features and benefits

APPENDIX

- Exchange rates

TABLES

- Table: Exchange rates, 2012

Fast Market Research (http://www.fastmr.com) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.